Unusual 11 Mid-Day Movers 10/23: (CPXX) (INFN) (BRP) Higher; (ADHD) (IBIO …StreetInsider.com (subscription)Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) 28.2% HIGHER; announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to purchase up to 661,115 shares of its common stock. The shares of common stock … …read more
Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of …BenzingaCelator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … and more …read more
Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of … – Benzinga Read More »
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …MarketWatchCelator Pharmaceuticals, Inc. CPXX, -4.33% a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … and more …read more
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public … – MarketWatch Read More »
Transgenomic Announces $2.375 Million Private Placement FinancingPharmiWeb.com (press release)For each share of common stock purchased investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and
Transgenomic Announces $2.375M Private Placement FinancingBenzingaFor each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and more …read more
Transgenomic Announces $2.375M Private Placement Financing – Benzinga Read More »
Transgenomic Announces $2.375 Million Private Placement FinancingMarketWatchFor each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and more …read
Transgenomic Announces $2.375 Million Private Placement Financing – MarketWatch Read More »
Comstock Holds Initial Closing for Private Placement OfferingDigitalJournal.comIn connection with the private placement, the Company has agreed to issue warrants (“Warrants,” and each a “Warrant”) to purchase shares of the Company’s Class A Common Stock (the “Class A Common Stock”) to purchasers other than CDS who purchase … and more …read more
Comstock Holds Initial Closing for Private Placement Offering – DigitalJournal.com Read More »
Comstock Holds Initial Closing For Private Placement OfferingBenzingaIn connection with the private placement, the Company has agreed to issue warrants (“Warrants,” and each a “Warrant”) to purchase shares of the Company’s Class A Common Stock (the “Class A Common Stock”) to purchasers other than CDS who purchase … and more …read more
Comstock Holds Initial Closing For Private Placement Offering – Benzinga Read More »
Canacol Energy Ltd. Announces Cash Settlement and Cancellation of WarrantsMarketwired (press release)Canacol is an exploration and production company with operations focused in Colombia and Ecuador. The Corporation’s common stock trades on the Toronto Stock Exchange, the OTCQX in the United States of America, and the Colombia Stock Exchange … and more …read more
Canacol Energy Ltd. Announces Cash Settlement and Cancellation of WarrantsSYS-CON Media (press release)Canacol is an exploration and production company with operations focused in Colombia and Ecuador. The Corporation’s common stock trades on the Toronto Stock Exchange, the OTCQX in the United States of America, and the Colombia Stock Exchange … and more …read more